109 related articles for article (PubMed ID: 12185701)
1. [Growth factors in pregnancy complications with preeclampsia].
Bielecki DA; Klonowska-Dziatkiewicz E; Jarocki S; Urban J
Ginekol Pol; 2002 May; 73(5):422-9. PubMed ID: 12185701
[TBL] [Abstract][Full Text] [Related]
2. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels.
Madazli R; Aydin S; Uludag S; Vildan O; Tolun N
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):797-802. PubMed ID: 12911439
[TBL] [Abstract][Full Text] [Related]
3. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia.
Polliotti BM; Fry AG; Saller DN; Mooney RA; Cox C; Miller RK
Obstet Gynecol; 2003 Jun; 101(6):1266-74. PubMed ID: 12798535
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia.
Baker PN; Krasnow J; Roberts JM; Yeo KT
Obstet Gynecol; 1995 Nov; 86(5):815-21. PubMed ID: 7566855
[TBL] [Abstract][Full Text] [Related]
5. [Angiogenic proteins: possible markers of physiopathological processes during fetal development].
Petersen TM; Larsen T; Nielsen HJ
Ugeskr Laeger; 2003 Aug; 165(32):3082-7. PubMed ID: 12951850
[TBL] [Abstract][Full Text] [Related]
6. Microvascular permeability is related to circulating levels of tumour necrosis factor-alpha in pre-eclampsia.
Anim-Nyame N; Gamble J; Sooranna SR; Johnson MR; Steer PJ
Cardiovasc Res; 2003 Apr; 58(1):162-9. PubMed ID: 12667958
[TBL] [Abstract][Full Text] [Related]
7. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia.
Livingston JC; Chin R; Haddad B; McKinney ET; Ahokas R; Sibai BM
Am J Obstet Gynecol; 2000 Dec; 183(6):1554-7. PubMed ID: 11120527
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor serum levels in pregnancy and preeclampsia.
Hefler L; Obermair A; Husslein P; Kainz C; Tempfer C
Acta Obstet Gynecol Scand; 2000 Jan; 79(1):77-8. PubMed ID: 10646821
[No Abstract] [Full Text] [Related]
9. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.
Bosio PM; Wheeler T; Anthony F; Conroy R; O'herlihy C; McKenna P
Am J Obstet Gynecol; 2001 Jan; 184(2):146-52. PubMed ID: 11174494
[TBL] [Abstract][Full Text] [Related]
10. New scope in angiogenesis: role of vascular endothelial growth factor (VEGF), NO, lipid peroxidation, and vitamin E in the pathophysiology of pre-eclampsia among Egyptian females.
El-Salahy EM; Ahmed MI; El-Gharieb A; Tawfik H
Clin Biochem; 2001 Jun; 34(4):323-9. PubMed ID: 11440734
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor is increased in patients with preeclampsia.
Kupferminc MJ; Daniel Y; Englender T; Baram A; Many A; Jaffa AJ; Gull I; Lessing JB
Am J Reprod Immunol; 1997 Oct; 38(4):302-6. PubMed ID: 9352019
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies.
Taylor RN; Grimwood J; Taylor RS; McMaster MT; Fisher SJ; North RA
Am J Obstet Gynecol; 2003 Jan; 188(1):177-82. PubMed ID: 12548214
[TBL] [Abstract][Full Text] [Related]
13. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia.
Sharkey AM; Cooper JC; Balmforth JR; McLaren J; Clark DE; Charnock-Jones DS; Morris NH; Smith SK
Eur J Clin Invest; 1996 Dec; 26(12):1182-5. PubMed ID: 9013097
[TBL] [Abstract][Full Text] [Related]
14. Pre-eclampsia and the microcirculation: a novel explanation.
Bates DO
Clin Sci (Lond); 2003 Apr; 104(4):413-4. PubMed ID: 12653686
[No Abstract] [Full Text] [Related]
15. VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia.
Brockelsby J; Hayman R; Ahmed A; Warren A; Johnson I; Baker P
Lab Invest; 1999 Sep; 79(9):1101-11. PubMed ID: 10496528
[TBL] [Abstract][Full Text] [Related]
16. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia.
Lyall F; Greer IA; Boswell F; Fleming R
Br J Obstet Gynaecol; 1997 Feb; 104(2):223-8. PubMed ID: 9070144
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia.
Koga K; Osuga Y; Yoshino O; Hirota Y; Ruimeng X; Hirata T; Takeda S; Yano T; Tsutsumi O; Taketani Y
J Clin Endocrinol Metab; 2003 May; 88(5):2348-51. PubMed ID: 12727995
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum vascular endothelial growth factor levels in patients with polycythemia vera and thrombotic complications.
Cacciola RR; Di Francesco E; Giustolisi R; Cacciola E
Haematologica; 2002 Jul; 87(7):774-5. PubMed ID: 12091131
[TBL] [Abstract][Full Text] [Related]
19. Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy.
Eddahibi S; Humbert M; Sediame S; Chouaid C; Partovian C; Maître B; Teiger E; Rideau D; Simonneau G; Sitbon O; Adnot S
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1493-9. PubMed ID: 11029367
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (VEGF) and discrimination between abnormal intrauterine and ectopic pregnancy.
Kucera-Sliutz E; Schiebel I; König F; Leodolter S; Sliutz G; Koelbl H
Hum Reprod; 2002 Dec; 17(12):3231-4. PubMed ID: 12456629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
